{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:50:15Z","timestamp":1792021815714,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacadv.2026.103109","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T21:00:15Z","timestamp":1786050015000},"page":"103109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atrial Fibrillation Burden and Clinical Outcomes After Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs"],"prefix":"10.1016","volume":"5","author":[{"given":"Zuzana","family":"Hejdukova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalibor","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-4218","authenticated-orcid":false,"given":"Marek","family":"Hozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Roubicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ranic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan","family":"Havranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Dusik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Souza\u2013Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Chovancik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1048-2598","authenticated-orcid":false,"given":"Jana","family":"Vesela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bulkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Benesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-4448","authenticated-orcid":false,"given":"Pavel","family":"Osmancik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103109_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib3","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacc.2025.04.042","article-title":"Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial","volume":"86","author":"Osmancik","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056522","article-title":"Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)","volume":"12","author":"Osmancik","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacadv.2026.103109_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103109_bib7","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103109_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103109_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103109_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.hrthm.2021.01.021","article-title":"Atrial fibrillation burden and heart failure: data from 39,710 individuals with cardiac implanted electronic devices","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacadv.2026.103109_bib11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacadv.2026.103109_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/ehaf689","article-title":"Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial","volume":"47","author":"Vermeer","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103109_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103457","article-title":"Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial","volume":"88","author":"Zeemering","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacadv.2026.103109_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf150","article-title":"Atrial fibrillation burden and symptom, quality of life, and healthcare resource utilization after cryoballoon ablation in persistent atrial fibrillation","volume":"27","author":"Yeo","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.jacadv.2026.103109_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacep.2025.02.006","article-title":"Reduction of AF burden after cryoballoon ablation in patients with early persistent AF: the COOL-PER trial","volume":"11","author":"Lee","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib16","article-title":"Obese patients with new onset atrial fibrillation\/flutter have higher risk of hospitalization, cardioversions, and ablations","volume":"40","author":"Norton","year":"2024","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.jacadv.2026.103109_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacep.2016.12.015","article-title":"Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation: the CENT study","volume":"3","author":"Pathak","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103109_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31083\/j.rcm2502071","article-title":"Quality of life and safety outcomes after first-line treatment of symptomatic AF with cryoablation or drug therapy: a meta-analysis of randomized controlled trials","volume":"25","author":"Song","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2026.103109_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028609","article-title":"Cardiovascular hospitalizations and resource use following atrial fibrillation ablation","volume":"12","author":"Dhande","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103109_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26005302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26005302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:27:01Z","timestamp":1792020421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26005302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2772963X26005302"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103109","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation Burden and Clinical Outcomes After Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103109"}}